Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EI24 autophagy associated transmembrane protein (EI24) is a multi-pass transmembrane protein implicated in the negative regulation of cell growth by inducing apoptosis through the caspase 9 and mitochondrial pathways, and it is involved in the formation of degradative autolysosomes during autophagy. EI24 expression is induced by p53 and has been characterized as a potential tumor suppressor, with the gene located at human chromosome 11q24—a region frequently disrupted in various cancers. Alternative splicing of EI24 generates multiple transcript variants, and the protein is evolutionarily conserved with homologs identified in other species. Functional roles also include contributions to cellular responses to genotoxic stress and autophagy regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EI24 autophagy associated transmembrane protein (EI24).